Disease, Health and Risk Profile · Tilapia & Catfish

Disease, Health and Biosecurity · Pillar 03

Since a virus tore through Lake Volta in 2018, disease has stopped being a background worry and become the first line of any honest tilapia plan. The virus is now endemic, it travels silently in fingerlings, and it can drop a cage's survival to as low as one fish in five. But the farmers themselves rank dirty water, not the pathogen, as the single biggest risk, and that reframes the whole problem: disease here is partly a water-management failure, which means it is partly manageable, and the gaps in screening, biosecurity and diagnostics are themselves the clearest business openings in the sector.

Rows of empty, weathered fish cages floating abandoned on Lake Volta at dawn, faded netting and rusted frames, still water, documentary Ghana aquaculture scene, natural light

Survival is the master variable

A single virus in 2018 erased roughly half the output of Ghana's fastest-growing food industry.

46%

of national output lost to the 2018 to 2019 ISKNV outbreak

5-20%

grow-out survival to harvest since the virus arrived

~80%

of farms now carry the endemic ISKNV virus

🐟 The 2018 crash reset the business case 🐟

You cannot understand tilapia in Ghana without the year 2018. 2018 brought the first detection of the ISKNV virus in Africa, with 60 to 90 percent mortality, and it was endemic across Lake Volta by July 2019 (Ramirez-Paredes et al., 2021). It arrived on a sector that had grown from almost nothing to more than 50,000 tonnes in a decade, and it did not spread slowly.

Within months, the 2018 to 2019 ISKNV outbreak cut national output to about 30,000 tonnes, an economic loss of about 46 percent (Ayiku et al., 2024). A single virus erased roughly half the output of Ghana's fastest-growing food industry in under a year. That is the event every cost model, every loan and every entry plan now sits downstream of, whether the person writing it knows it or not.

🔍 WHAT THIS MEANS

The lesson of 2018 is not that fish farming is doomed; it is that disease is the first variable, not the last. An entrant who models feed, price and growth but treats a wipe-out as a remote tail risk has the plan upside down. Survival is the number that decides whether every other number matters. Build the plan around protecting it, and the economics follow; ignore it, and the best feed price in Ghana will not save the cage.

🐟 The virus is endemic, and it hides in healthy-looking fish 🐟

Figure 8 ISKNV as a lake-wide condition: endemic across Lake Volta, moving in fingerlings and hiding in asymptomatic carriers. The virus is not a farm problem but a lake problem: it is endemic across the water, moves in fingerlings, and hides in fish that look healthy. Sources: Ramirez-Paredes et al. (2021); Ayiku et al. (2024).

~50%

of infected fish show no symptoms, so it spreads silently

63%

of farms buy seed from disease-positive farms

The harder truth is that the 2018 outbreak never really ended; it settled in. The virus is now found on about 80 percent of farms at about 40 percent average daily mortality, and about half of infected fish show no symptoms, so it spreads silently through fingerling sales (Ayiku et al., 2024). Two features make this virus so difficult. First, it is a lake problem, not a farm problem: it is present across the water, so a clean site is only ever as clean as its neighbours and its seed.

Second, and worse, it is silent. Because about half of infected fish look perfectly healthy, the fish that carries the virus onto a new farm shows no symptom until it is too late, and the main road it travels is the fingerling trade. About 63 percent of farms buy seed from disease-positive farms (Ayiku et al., 2024), which means most stocking decisions are, unknowingly, disease decisions.

📡 MARKET SIGNAL: HEALTH STATUS IS THE THING NO ONE CAN PROVE

The silent-carrier problem is a market signal as much as a disease fact. It says the scarce, valuable thing in this sector is trust in a fish's health status, and right now almost no one can prove it. A hatchery or nursery that can screen and certify its seed, or a diagnostic service that can test a batch before it is stocked, is selling exactly the certainty the silent carrier destroys. The disease that is killing the sector and the opening inside it are the same fact seen from two sides.

🐟 Survival is now the first number, and it has collapsed 🐟

The clearest measure of the damage is survival to harvest, and the recent figures are sobering. Grow-out survival can fall to about 5 to 20 percent, mortalities can top 50 percent, and about 1,200 cages have been abandoned on Lake Volta (Baah et al., 2026). Put plainly, a farmer can stock a full cage, feed it for months, and bring one fish in five to market.

Before the virus, survival in the 50 to 60 percent range was normal (Trinh et al., 2021); the abandoned cages on the lake are the physical record of farmers for whom the numbers stopped working. This is why survival, not growth rate or feed conversion, is the master variable of the whole business: a cage that grows fast but survives at 20 percent loses money, while a slower cage that survives at 70 percent makes it.

>50%

mortalities that grow-out cages can now top

~1,200

cages abandoned on Lake Volta as the numbers stopped working

Figure 9 The survival collapse: grow-out survival before and after the 2018 virus, and the cages abandoned in its wake. Since the 2018 virus, farm survival has collapsed from something workable to as low as one fish in five. Disease is now the first number in any honest business plan. Sources: Trinh et al. (2021); Baah et al. (2026).

🔍 WHAT THIS MEANS

For anyone building a cost model (Pillar 5), this is the single most important input. Do not model survival at a hopeful 80 or 90 percent. Model a realistic band, stress-test the plan at 40 to 50 percent, and check it still survives a bad cycle. The farms that fail are almost always the ones that assumed the good case and had no plan for the likely one.

ISKNV, the endemic virus that crashed Ghana's tilapia sector in 2018 — The first number The endemic ISKNV virus

Mass mortality of tilapia in a cage after a disease die-off on Lake Volta — The first number Mass mortality in the cage

Poor water quality and low oxygen on a crowded cage site, the stress that lets disease kill — The first number Poor water and low oxygen

🐟 Water pollution is the number-one risk, which is the hopeful part 🐟

Here is the finding that turns the pillar from a death notice into a plan. When farmers on the lake were asked to rank what actually threatens their fish, they did not put the virus first. Farmers rank water pollution the single biggest risk factor at about 34.6 percent, ahead of pathogens at about 30.8 percent, so disease is partly a water-management problem (Baah et al., 2026).

This matters enormously, because water quality is partly within a farmer's control in a way a virus is not. Poor water, low dissolved oxygen, pollution from mining and waste, and overcrowded cages are the stresses that let endemic disease turn into a die-off. A well-sited, well-oxygenated, sensibly stocked cage does not make the virus disappear, but it stops the virus finding the opening it needs. Disease here is, in large part, a water-management problem wearing a pathogen's name, and that is genuinely good news, because management can be taught, bought and sold.

34.6%

farmers rank water pollution the single biggest risk factor

30.8%

pathogens ranked second, behind dirty water

A Ghanaian fish farmer lowering a handheld dissolved-oxygen probe into the water beside a floating tilapia cage on Lake Volta, morning light, documentary aquaculture scene

Partly within a farmer's control

A well-oxygenated, sensibly stocked cage stops the virus finding the opening it needs.

Overcrowded cages in poorly flushed, polluted water, the stress that turns endemic disease into a die-off

A pathogen's name on a water problem

Poor water, low oxygen and crowding are the stresses that let endemic disease turn into a die-off.

The table sets out the real threats the way a farmer or investor should read them: what each one does, how it moves, how it is managed, and the business opening hiding inside the gap.

Table 4: The real disease and health threats to Ghana tilapia, read for management and for the opening inside each
Threat	What it does	How it spreads / worsens	How to manage it, and the opening
ISKNV virus	Silent mass mortality; survival down to 5-20 percent	Fingerlings from positive farms; water between cages; stress	Screened seed, isolation, water surveillance. Opening: certified seed and pre-stocking diagnostics
Streptococcus agalactiae	Co-dominant bacterial killer; ~73 percent mortality in Egyptian challenge trials	Stress, warm water, crowding and poor water quality	Lower density, clean water, targeted treatment. Opening: vet advisory and lab-led diagnosis
Poor water and low oxygen	The #1 farmer-ranked risk; triggers stress die-offs	Mining and domestic pollution, overstocking, oxygen crashes	Siting, oxygen monitoring, aeration. Opening: water-monitoring and sensor services
Antibiotic overuse and AMR	Resistance and residues; long-run market and health risk	Unregulated, often unprescribed antibiotic use	Prescription discipline, diagnosis before dosing. Opening: vet and lab testing capacity
TiLV virus (not yet in Ghana)	Watch-list; causes losses at all stages where present	Would enter via imported live fish or unscreened seed	Border biosecurity and screening. Opening: surveillance and quarantine capacity

Sources: Baah et al. (2026); Ayiku et al. (2024); Ramirez-Paredes et al. (2021); Algammal et al. (2025, Egypt); Dandi et al. (2024, 2026).

🐟 Streptococcus, antibiotics and the residue question 🐟

The virus is not the only killer. Streptococcus agalactiae is the co-dominant killer alongside the virus, and species-level challenge trials on Egyptian farm isolates put its mortality near 73 percent in seven days with about 36 percent of strains resistant to several drugs (co-dominant status per Baah et al., 2026; species-level figures from Algammal et al., 2025, Egypt). Bacteria such as this are opportunists: they strike hardest when fish are already stressed by warm, crowded, dirty water, which ties the bacterial problem straight back to water management.

Faced with dying fish and no lab to tell them why, farmers reach for antibiotics, and they reach hard. Every surveyed cage farmer on Lake Volta uses antibiotics, about 41 percent without a prescription, and banned residues have been found in fish muscle, though the measured risk to people is still low (Dandi et al., 2024, 2026). That is a real long-run problem, because unprescribed, guess-based dosing is exactly how drug resistance is bred.

~73%

Streptococcus mortality in seven days in Egyptian challenge trials

41%

of cage farmers use antibiotics without a prescription

Antibiotics dosed by hand into feed on a Ghanaian cage farm, without a label or a prescription

Dosed by hand, without a label

The everyday reality behind the resistance statistic: antibiotics dosed by hand, without a label or a prescription.

Streptococcus agalactiae, the co-dominant bacterial killer, striking stressed tilapia in warm crowded water

The co-dominant killer

Bacteria strike hardest when fish are already stressed, tying the problem back to water management.

But the picture must be kept balanced, because the alarm is easy to overstate. The banned residues that have been found are a warning sign about farm practice and future resistance, not evidence that Ghanaian farmed tilapia is unsafe to eat: measured human-health risk quotients sit well below the threshold of one, and retail tilapia tested in Tema fell within safety limits (Dandi et al., 2024; Magna et al., 2024). The honest reading is that antibiotic misuse is a management and stewardship failure to fix now, before it becomes a public-health and market-access problem, rather than a food-safety scandal today. The fix is not more drugs; it is diagnosis before dosing, which is another reason the diagnostic gap is a business, not just a risk.

🐟 The biosecurity gap and the new government labs 🐟

If disease is the first number, biosecurity is the cheapest lever on it, and Ghana has barely pulled it. Only 3 of 30 surveyed farms had a physical biosecurity barrier, and the ISKNV vaccine is unproven, with 12 of 13 vaccinated farms still testing positive (Ayiku et al., 2024). A vaccine looked like the escape route, but it has disappointed: of the farms that vaccinated against ISKNV, almost all stayed positive, and no proper efficacy trial was ever done.

For now there is no silver bullet in a syringe. What works is unglamorous and cheap: screen the seed, isolate new stock, keep the water clean, avoid moving fish between sites, and monitor oxygen. The reason more farms do not do it is not cost; it is that no one has packaged and sold it to them, which is the opening.

There is also a genuine signal from government worth reading carefully. The government opened three regional fish-health laboratories at Kumasi, Ho and Koforidua in late 2025, plus histopathology and molecular diagnostics (Ghana News Agency, 2025). After years in which farmers diagnosed disease by eye and peer rumour, the state is finally building the testing infrastructure the sector has always lacked.

A technician in a white coat examining tilapia tissue samples under a microscope in a clean modern Ghanaian fish-health diagnostic laboratory, molecular testing equipment on the bench, natural light

Kumasi, Ho and Koforidua

Three regional fish-health labs opened in late 2025, the testing infrastructure the sector always lacked.

A worker inspecting and dipping a net in disinfectant beside an isolated tilapia nursery tank on a Ghanaian farm, simple biosecurity barrier, documentary aquaculture scene, natural light

Unglamorous and cheap

Screen the seed, isolate new stock, monitor oxygen: what works costs little, but no one has sold it.

3 of 30

surveyed farms had any physical biosecurity barrier

12 of 13

vaccinated farms still tested positive; the vaccine is unproven

This is a real change, and it is the enabling backbone for every private diagnostic, screening and advisory service in this pillar: the labs create the capacity to certify health, and private operators can build the services that put that capacity to work on farms.

🐟 The risks that sit inside the health of the fish 🐟

Filter the register by severity to narrow it to the threats that matter most on your cage.

Filter by severity

ISKNV and the silent-carrier problem

VERY HIGH

What it is

The virus that crashed the sector in 2018 is now endemic across Lake Volta and spreads silently, because about half of infected fish show no symptoms and most farms buy seed from other, often positive, farms. A clean-looking batch of fingerlings can carry a wipe-out onto a healthy site.

Evidence

The virus is on about 80 percent of farms at around 40 percent average daily mortality, about half of positive fish are asymptomatic, and roughly 63 percent of farms source seed from disease-positive farms (Ayiku et al., 2024).

Who it hits

Every grow-out farmer on the lake, but hardest on newcomers who stock unscreened seed on a hopeful survival assumption.

How to manage it, and the opening

Stock only screened seed, isolate and test-batch new stock, and model survival conservatively. The mirror-image opening is certified seed and pre-stocking diagnostics, because the trust the silent carrier destroys is a market.

Streptococcus and multi-drug resistance

HIGH

What it is

Streptococcus agalactiae is the co-dominant killer alongside the virus, striking stressed fish in warm, crowded, poor-quality water. A growing share of strains resist multiple drugs, so the antibiotics farmers reach for are quietly losing their power.

Evidence

Experimental mortality reaches about 73 percent in seven days and roughly 36 percent of strains are multi-drug resistant (Baah et al., 2026; species-level data from Algammal et al., 2025, Egypt).

Who it hits

Farmers on warm, shallow, overstocked sites, and any farm treating by guesswork rather than diagnosis.

How to manage it, and the opening

Cut the stress that lets it strike, lower density and manage water, and treat on a diagnosis, not a hunch. The opening is vet advisory and lab-led diagnosis that replaces guess-based dosing.

Antibiotic overuse and residues

MEDIUM

What it is

With no lab to tell them why fish are dying, farmers dose heavily and often without a prescription, breeding resistance and leaving residues, including internationally banned drugs, in fish and sediment. It is a stewardship and future-market risk more than a present food-safety emergency.

Evidence

Every surveyed cage farmer uses antibiotics, about 41 percent without a prescription, and banned residues have been found in muscle, though measured human-health risk quotients stay below one (Dandi et al., 2024; Magna et al., 2024).

Who it hits

The sector's long-run reputation and export ambition, and consumers if practice worsens; not, on current evidence, today's fish eaters.

How to manage it, and the opening

Move to diagnosis before dosing and prescription discipline. The opening is diagnostic and vet capacity, plus certified low-antibiotic production for a premium and export lane.

The water-quality blind spot

HIGH

What it is

Farmers themselves rank poor water and low oxygen the single biggest risk, ahead of pathogens, yet most farms do not monitor it. Pollution from mining and waste, oxygen crashes and overstocking are the stresses that let endemic disease turn into a die-off.

Evidence

Water pollution is ranked the number-one risk factor at about 34.6 percent, ahead of pathogens at 30.8 percent (Baah et al., 2026).

Who it hits

Every cage on the lake, and especially farms sited in polluted or poorly flushed water without oxygen monitoring.

How to manage it, and the opening

Site carefully, avoid crowding, and monitor oxygen. The opening is a solar sensor and text-alert service, the most feasible technology win in the sector, attacking the exact stress that lets disease kill.

🐟 The Opening: where the disease gaps become a business 🐟

01

Water-quality monitoring as a service. Because dirty water and low oxygen are the ranked number-one risk, a cheap solar sensor with a text alert (see AquaMet in Pillar 8) attacks the exact stress that lets disease kill. This is the most feasible technology opening in the whole sector today.

02

A pre-stocking diagnostic and fish-health advisory service. Testing a seed batch before it enters a cage, and advising on stocking and water, sells directly against the silent-carrier problem.

03

A biosecurity supply and installation service: the simple foot-dips, nets, isolation and screening routines that almost no farm has yet, packaged for a farmer who knows they need them but not how.

04

A fish-health advisory and biosecurity practice, working with the new Kumasi, Ho and Koforidua labs to turn public testing capacity into on-farm screening, diagnosis and biosecurity plans, which the 2025 Act now requires commercial farms to hold (see Pillar 7).

05

A private diagnostics or sample-logistics service that gets fish and water samples from lakeside farms to the labs and results back quickly, closing the gap between capacity and the cage.

🐟 Key takeaways 🐟

01

Disease is the first number in a tilapia plan, not the last. The 2018 virus cut national output by about 46 percent, and everything downstream now sits on top of that fact.

02

The virus is endemic and silent. It is on most farms, about half of infected fish look healthy, and it travels in the fingerling trade, so most stocking decisions are unknowingly disease decisions.

03

Survival, not growth, is the master variable. Grow-out survival can fall to 5 to 20 percent, so model it conservatively and stress-test the plan at a bad cycle.

04

Disease is partly a water problem, which is the hopeful part. Farmers rank dirty water the top risk, and water is partly controllable, so clean, well-oxygenated, sensibly stocked cages give the virus less to work with.

05

The gaps are the openings. Screening, diagnostics, biosecurity services and water-quality monitoring, now backed by the new government labs, are the clearest businesses in the pillar. TiLV is a watch-list threat, not present in Ghana.

Written for each reader

🐟 Practitioner intelligence 🐟

Hover any card to pause and lift it.

For students

Do not think of disease as a topic to memorise; think of it as the variable that decides every business plan you will ever write in this sector. The most useful thing you can learn is not the biology of the virus but the practice that contains it: how to screen a batch of seed, how to read dissolved oxygen, how to keep new stock isolated. A student who can walk onto a farm and run a simple biosecurity and water-quality check is selling the scarcest skill on the lake, and it needs almost no capital to start.

For entrepreneurs

Your first move is not to buy cages; it is to decide how you will keep fish alive. Lock a screened, certified seed source, model survival at a realistic 40 to 60 percent rather than a hopeful 80, and put oxygen monitoring and a simple biosecurity routine in place before you stock. The trap that kills first-timers is treating a wipe-out as a remote risk and stocking cheap, unscreened seed on an optimistic survival number. If you would rather sell to farmers than farm, the biggest openings here are seed screening, water-quality monitoring and fish-health advisory, all of which are under-served.

For investors

Underwrite survival before you underwrite anything else. A grow-out venture that cannot show where its seed comes from, whether it is screened, and how it monitors water is a disease position dressed as a farm, and the abandoned cages on the lake are the evidence. Ask for the survival assumption, reject the hopeful case, and test whether the plan survives a 40 to 50 percent cycle. The thesis worth backing is the picks-and-shovels side: certified hatcheries, diagnostics, biosecurity and water-monitoring services, whose market is every farm exposed to the endemic virus and whose demand the new Act and labs are now compelling.

For ecosystem actors

The highest-leverage move is to turn the new fish-health labs into on-farm capacity: fund the sample logistics, certification schemes and advisory services that connect the Kumasi, Ho and Koforidua labs to the cages, and tie public seed and licensing support to proven health screening, as the 2025 Act now requires. Measure success as the share of stocked seed that is screened and the share of farms monitoring water, not as fish handed out. The failure to avoid is subsidising unscreened seed and unadvised antibiotic use, which spends public money spreading the very problems it should be solving.

For students

Do not think of disease as a topic to memorise; think of it as the variable that decides every business plan you will ever write in this sector. The most useful thing you can learn is not the biology of the virus but the practice that contains it: how to screen a batch of seed, how to read dissolved oxygen, how to keep new stock isolated. A student who can walk onto a farm and run a simple biosecurity and water-quality check is selling the scarcest skill on the lake, and it needs almost no capital to start.

For entrepreneurs

Your first move is not to buy cages; it is to decide how you will keep fish alive. Lock a screened, certified seed source, model survival at a realistic 40 to 60 percent rather than a hopeful 80, and put oxygen monitoring and a simple biosecurity routine in place before you stock. The trap that kills first-timers is treating a wipe-out as a remote risk and stocking cheap, unscreened seed on an optimistic survival number. If you would rather sell to farmers than farm, the biggest openings here are seed screening, water-quality monitoring and fish-health advisory, all of which are under-served.

For investors

Underwrite survival before you underwrite anything else. A grow-out venture that cannot show where its seed comes from, whether it is screened, and how it monitors water is a disease position dressed as a farm, and the abandoned cages on the lake are the evidence. Ask for the survival assumption, reject the hopeful case, and test whether the plan survives a 40 to 50 percent cycle. The thesis worth backing is the picks-and-shovels side: certified hatcheries, diagnostics, biosecurity and water-monitoring services, whose market is every farm exposed to the endemic virus and whose demand the new Act and labs are now compelling.

For ecosystem actors

The highest-leverage move is to turn the new fish-health labs into on-farm capacity: fund the sample logistics, certification schemes and advisory services that connect the Kumasi, Ho and Koforidua labs to the cages, and tie public seed and licensing support to proven health screening, as the 2025 Act now requires. Measure success as the share of stocked seed that is screened and the share of farms monitoring water, not as fish handed out. The failure to avoid is subsidising unscreened seed and unadvised antibiotic use, which spends public money spreading the very problems it should be solving.

Where this connects. The disease that dominates this pillar begins with the disease-carrying fingerling introduced in Pillar 1, so seed certification is the shared fix. Because disease is largely a water-management problem, it runs straight into the production regime, siting and stocking choices of Pillar 4, and the collapsed survival modelled here is the master input to the cost and returns model in Pillar 5, where one bad cycle decides whether the economics work.